← FDA Drug Approvals (Drugs@FDA)

NALOXONE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2022-11-07

Drug application

FDA Application #
ANDA214792
Application type
Abbreviated New Drug Application (Generic)
Brand name
NALOXONE HYDROCHLORIDE
Generic name
NALOXONE HYDROCHLORIDE
Active ingredients
NALOXONE HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
BAXTER HLTHCARE CORP
Manufacturer
Baxter Healthcare Corporation
First approval
2022-11-07

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown